C. A. Paucar, “Pyrazinamide-derived hydrazone outperforms pyrazinamide activity in Mycobacterium tuberculosis DM97: an in vitro and in silico study”, Eclét. Quím., vol. 51, p. e–1506, Jun. 2026.